eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | gastrointestinal stromal tumor |
| Comorbidity | C0023418|leukemia |
| Sentences | 3 |
| PubMedID- 24348666 | It was initially proposed that the t790m mutation might prevent the proper binding of tyrosine kinase inhibitors via steric hindrance, similar to the corresponding gatekeeper mutations in bcr-abl (t315i) and kit (t670i) that confer resistance to imatinib (gleevec) in chronic myelogenous leukemia and in patients with gastrointestinal stromal tumors. |
| PubMedID- 21120166 | Synchronous development of kit positive acute myeloid leukemia in a patient with gastrointestinal stromal tumor. |
| PubMedID- 22009701 | Imatinib mesylate is a drug that has been approved for treatment of advanced gastrointestinal stromal tumors (gists) and patients with leukemia such as chronic myeloid or philadelphia chromosome-positive acute lymphoblastic. |
Page: 1